DE2705892A1 - 3-(2-substit.-benzimidazolyl)-alanine - Google Patents

3-(2-substit.-benzimidazolyl)-alanine

Info

Publication number
DE2705892A1
DE2705892A1 DE19772705892 DE2705892A DE2705892A1 DE 2705892 A1 DE2705892 A1 DE 2705892A1 DE 19772705892 DE19772705892 DE 19772705892 DE 2705892 A DE2705892 A DE 2705892A DE 2705892 A1 DE2705892 A1 DE 2705892A1
Authority
DE
Germany
Prior art keywords
methyl
acid
amino
compounds
benzimidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772705892
Other languages
German (de)
English (en)
Inventor
Patrick Stephen Callery
Jeremy Wright
Nicholas Zenker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2705892A1 publication Critical patent/DE2705892A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19772705892 1976-02-13 1977-02-11 3-(2-substit.-benzimidazolyl)-alanine Withdrawn DE2705892A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/657,829 US4073929A (en) 1976-02-13 1976-02-13 3-(2-Substitutedbenzimidazolyl) alanines

Publications (1)

Publication Number Publication Date
DE2705892A1 true DE2705892A1 (de) 1977-08-18

Family

ID=24638816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772705892 Withdrawn DE2705892A1 (de) 1976-02-13 1977-02-11 3-(2-substit.-benzimidazolyl)-alanine

Country Status (9)

Country Link
US (1) US4073929A (enExample)
JP (1) JPS5297967A (enExample)
CH (1) CH625228A5 (enExample)
DE (1) DE2705892A1 (enExample)
DK (1) DK31277A (enExample)
FR (1) FR2340935A1 (enExample)
GB (1) GB1521025A (enExample)
NL (1) NL7700947A (enExample)
SE (1) SE7701506L (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070478A (en) * 1977-02-17 1978-01-24 Merck & Co., Inc. Benzimidazole substituted alanines
DE2801980A1 (de) * 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4537907A (en) * 1980-10-06 1985-08-27 University Of Illinois Foundation Hypnotic composition and method of inducing sleep
AU2001267465B2 (en) * 2000-05-30 2006-02-02 Boehringer Ingelheim Animal Health USA Inc. Methods for prevention of ulcers and improving physiological performance

Also Published As

Publication number Publication date
JPS5297967A (en) 1977-08-17
DK31277A (da) 1977-08-14
CH625228A5 (enExample) 1981-09-15
FR2340935B1 (enExample) 1978-11-17
SE7701506L (sv) 1977-08-14
FR2340935A1 (fr) 1977-09-09
NL7700947A (nl) 1977-08-16
GB1521025A (en) 1978-08-09
US4073929A (en) 1978-02-14

Similar Documents

Publication Publication Date Title
DE3522604A1 (de) Neue feste formen von 2-(gamma)thoxy-4-(n-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)-benzoesaeure, diese formen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE2366106B1 (de) 2-Amino-6,7-dimethoxy-4-(methoxysubstituierte-1,2,3,4-tetrahydroisochinolin-2-yl)-chinazolinderivate,Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0116276B1 (de) Neue spirocyclische Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung sowie neue spirocyclische Aminosäuren als Zwischenprodukte und Verfahren zu deren Herstellung
EP0733052B1 (de) Bicyclen-derivate, ihre herstellung und verwendung
DE2238504B2 (de) l-Phenoxy-3-alkylaminopropan-2-ol -Derivate
DE2851435A1 (de) Substituierte amid-derivate des l- und dl-phenylglycins, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE2446758C3 (de) 2-(2-Fluor-6-trifluormethylphenylimino)-imidazolidin, dessen Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung der Hypertonie
DE69424183T2 (de) 6-(2-imidazolinylamino)chinolin-verbindungen als alpha-2-adrenoceptor-antagonisten
CH619462A5 (en) Process for the preparation of novel piperazinylpyrazines
DE2150436A1 (de) Neue organische Verbindungen,ihre Herstellung und ihre Verwendung
DE4132631A1 (de) Imidazolyl-propensaeurederivate
DE2705892A1 (de) 3-(2-substit.-benzimidazolyl)-alanine
AT391320B (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE3314878C2 (enExample)
DE69015834T2 (de) 6-Chlor-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzodiazepin-carbamate als Pro-Arzneimittel.
DE1931081A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
DE10044905A1 (de) (2-Azabicyclo[2.2.1]hept-7-yl)methanol-Derivate als nikontinische Acetylcholinrezeptor Agonisten
DD205682A5 (de) Verfahren zur herstellung von (-)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3-diazacyclopent-2-en und seinen salzen
DE2705844A1 (de) 2-amino-3-benzoxazolylpropionsaeureverbindungen
EP0113880A2 (de) Neue 2-Azabicyclo(2.2.1)heptan-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung sowie 2-Azabicyclo(2.2.1)heptan-Derivate als Zwischenprodukte und Verfahren zu deren Herstellung
DE3222779C2 (enExample)
DE3650311T2 (de) Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie.
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2705883A1 (de) Neue anti-hypertonische zubereitungen
EP0972515A2 (de) Cyclooxygenase-Inhibitor

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee